Big Gain For Immunovant, Inc.

Fri, Aug 19, 2022 at 06:58 PM
Big Gain For Immunovant, Inc.

Immunovant, Inc. (IMVT:NASDAQ) jumped higher at $6.21, representing a gain of 21.1%. On Fri, Aug 19, 2022, IMVT:NASDAQ hit a New 2-Week High of $6.21. The stock appeared on our News Catalysts scanner on Thu, Aug 18, 2022 at 12:44 PM in the 'BIOTECH' category. From Fri, Aug 05, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days

The stock spiked on Thu, Mar 17, 2022 at $6.59 with a volume of 1M+.

About Immunovant, Inc. (IMVT:NASDAQ)

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.